Login

Financial Snapshot

Revenue
TTM
$268.2M
Gross Margin
TTM
3.77%
Net Income
TTM
-$623.0M
Current Assets
2023 Q1
Current Liabilities
2023 Q1
Current Ratio
2023 Q1
51.76%
Total Assets
2023 Q1
Total Liabilities
2023 Q1
Book Value
2023 Q1
-$648.1M
Cash
2023 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$404.9M

Stock Price

Loading...
Market Cap: $738.77 Thousand

About AMYRIS, INC.

Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 1,598 full-time employees. The company went IPO on 2010-09-28. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The firm leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.

Industry: Industrial Organic Chemicals Peers: Aspen Aerogels Inc CHASE CORP Danimer Scientific, Inc. Diversey Holdings, Ltd. Ecovyst Inc Minerals Technologies Inc Sherwin-Williams Co Valhi Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support